• Leave Your Message
    Products Categories
    Featured Products

    PARENT NUCLEUS OF CEFOZOPRAN CAS No. 197897-11-3 Pharmaceutical Intermediates

    Product name

    PARENT NUCLEUS OF CEFOZOPRAN

    Other name

    1-[((7R)-7-AMINO-4-CARBOXY-3,4-DIDEHYDROCEPHAM-3-YL)METHYL]-1H-IMIDAZO[1,2-B]PYRIDAZIN-4-IUM IODIDE

    CAS No. 

    197897-11-3

    EINECS  

    606-382-0

    Formula 

    C14H14IN5O3S

    Molecular Weight

    459.26

    Appearance

    white to off-white crystalline powder

    Purity

    ≥98%

    Type

    Pharmaceutical Intermediates

    - High Purity: Our Parent Nucleus of Cefozopran is manufactured with exceptional purity, ensuring optimal performance in pharmaceutical applications.

    - Key Intermediate: This compound serves as a crucial building block in the synthesis of Cefozopran, a broad-spectrum cephalosporin antibiotic.

    - Versatile Applications: The Parent Nucleus is utilized in various fields, including medicinal chemistry and drug development, due to its unique structural properties.

    - Reliable Supply Chain: As a leading foreign trade company, we ensure a consistent and reliable supply of the Parent Nucleus of Cefozopran to meet your pharmaceutical needs.

    - Comprehensive Technical Support: Our team of experts is available to provide guidance and support throughout the procurement process, ensuring you receive the best product for your applications.

      Product details

      161798-03-4 (3)
      02

      introduce

      Etoricoxib intermediate is an important component used in the pharmaceutical industry to synthesize etoricoxib, a nonsteroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic and antipyretic properties. Our factory integrates production and trading to ensure the highest quality standards and reliable supply of etocoxib intermediates to meet the diverse needs of pharmaceutical manufacturers.
      608141-42-0 (1)
      02

      Physical and chemical properties

      - Etoricoxib intermediates have high purity and precise composition, ensuring consistent performance during etoricoxib synthesis.
      - The product's stability and solubility make it suitable for use in pharmaceutical formulations, helping to improve the efficacy and quality of the final drug product.
      - Its unique chemical properties and molecular structure make it an important intermediate in the production of etoricoxib, a drug widely used to treat pain and inflammation.

      advantage

      - Our Etoricoxib intermediates are known for their superior quality and reliability, meeting the stringent requirements of the pharmaceutical industry.
      - The comprehensive production and trading capabilities of our factory ensure the continuous supply and timely delivery of etocoxib intermediates.
      - We prioritize customer satisfaction and offer competitive prices, making our products a cost-effective and reliable choice for pharmaceutical manufacturers.

      Uses in the pharmaceutical industry

      Etoricoxib intermediates play a vital role in the pharmaceutical industry and are key components in the synthesis of etoricoxib. This NSAID is widely used to treat a variety of conditions, including osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute pain. Pharmaceutical manufacturers rely on our high-quality intermediates to ensure the effectiveness, safety and consistency of final etoricoxib formulations, thereby improving the overall quality of patient care.
      In summary, etoricoxib intermediates are an important part of the pharmaceutical industry with exceptional quality, reliability and versatility. With our comprehensive manufacturing and trading capabilities, we are committed to meeting the diverse needs of pharmaceutical manufacturers by providing quality intermediates that meet the highest standards of excellence.